NEXT

New Jersey Law Journal

After Drug Company Executives' RICO Convictions, Suit Over NJ Woman's Death Shifts Into High Gear

Founder and former chief executive John Kapoor and four other Insys executives were found guilty of charges that they made payouts to doctors who prescribed their products and misled insurance companies about whether patients needed the drugs.
4 minute read

Litigation Daily

Pennsylvania Judge Tosses 173 Zostavax Complaints, Issues Warning to Plaintiffs Counsel

Judge Harvey Bartle III said that the complaints were "full of boilerplate language unrelated to the individual case," and were "the antitheses of how a proper federal complaint should be drafted."
4 minute read

The Legal Intelligencer

US Judge Tosses 173 Zostavax Complaints, Issues Warning to Plaintiffs Counsel

Judge Harvey Bartle III said that the complaints were "full of boilerplate language unrelated to the individual case," and were "the antitheses of how a proper federal complaint should be drafted."
4 minute read

New Jersey Law Journal

Amarin Fails in Bid to Push Unfair Competition Claim to ITC Prior to FDA Guidance

The court ruled that private parties may not enforce unfair competition claims based on the Food, Drug and Cosmetic Act at the ITC—at least not until the Food and Drug Administration has provided guidance on the precise issue in dispute.
5 minute read

Delaware Business Court Insider

Sandoz Released From Suit Targeting Planned Generic Lung Treatment Competitor

A Delaware federal judge on Thursday approved an agreement by San Francisco-based Genentech and Sandoz to dismiss the two entities, without prejudice, from the lawsuit, because neither had been involved in filing an abbreviated new drug application at the heart of the dispute.
3 minute read

The Legal Intelligencer

Cannabis and Hemp Industry Trembles After FDA Cracks the Whip

With the FDA "locked and loaded," and billions of annual sales and "deal flow capital" hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims.
10 minute read

Litigation Daily

ITC Can't Referee Food and Drug Competition Claims Ahead of FDA

The Federal Circuit ruled that private parties can't litigate violations of the Food, Drug and Cosmetic Act at the ITC—at least not until FDA provides guidance. The appellate court also affirmed the ITC's discretion to decline certain investigations.
5 minute read

National Law Journal

ITC Can't Referee Food and Drug Competition Before FDA Does

The Federal Circuit ruled that private parties can't litigate violations of the Food, Drug and Cosmetic Act at the ITC—at least not until FDA provides guidance. The appellate court also affirmed the ITC's discretion to decline certain investigations.
5 minute read

New Jersey Law Journal

Ethicon Hit With $120 Million Pelvic Mesh Verdict

The verdict came after a three-week trial, and the award included $20 million in compensatory damages, as well as $100 million in punitive damages.
3 minute read

The Legal Intelligencer

Philadelphia Jury Slams J&J With $120M Pelvic Mesh Verdict

The verdict came after a three-week trial in Judge Kenneth Powell's courtroom, and the award included $20 million in compensatory damages, as well as $100 million in punitive damages.
3 minute read

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now